Regina E. Groves
Director · AtriCure, Inc.
IndividualSelling only
- 2025
- Sep 14, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Regina E. Groves files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sven Wehrwein - $1.32M in ATRC purchases and sales in the last 12 months
- Salvatore Privitera - $880K in ATRC purchases and sales in the last 12 months
- Vinayak Doraiswamy - $523K in ATRC purchases and sales in the last 12 months
- Karl S. Dahlquist - $458K in ATRC purchases and sales in the last 12 months
- Justin J. Noznesky - $433K in ATRC purchases and sales in the last 12 months
- Maggie Yuen - $242K in ATRC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Regina E. Groves?
Regina E. Groves is a corporate insider, tracked as Director of AtriCure, Inc. (ATRC). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Regina E. Groves submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Regina E. Groves been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($378K) across all tracked filings.
